We are live on ! Find out more
FHTX icon

Foghorn Therapeutics
FHTX

90 hedge funds and large institutions have $148M invested in Foghorn Therapeutics in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 30 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

3% more funds holding

Funds holding: 87 → 90 (+3)

0.28% more ownership

Funds ownership: 72.41% → 72.69% (+0.28%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

13% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 30

22% less capital invested

Capital invested by funds: $190M → $148M (-$42.4M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $3K

Holders
90
Holders Change
+3
Holders Change %
+3.45%
% of All Funds
1.21%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
26
Reduced
30
Closed
5
Calls
–
Puts
$3K
Net Calls
-$3K
Net Calls Change
-$7K

Top Buyers

1
Raymond James Financial
Raymond James Financial
Florida
+$861K
2
DCM
DAFNA Capital Management
California
+$538K
3
SCM
SCS Capital Management
Massachusetts
+$488K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$387K
5
Squarepoint
Squarepoint
New York
+$201K

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$460K
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$390K
3
Millennium Management
Millennium Management
New York
-$328K
4
BBA
Baker Bros. Advisors
New York
-$213K
5
JP Morgan Chase
JP Morgan Chase
New York
-$184K
Name Holding Trade Value Shares
Change 		Change in
Stake
FP
1
Flagship Pioneering
Massachusetts
$46.3M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$20.4M -$460K -100,845 -2%
BI
3
BVF Inc
California
$19.4M – – –
DM
4
Deerfield Management
New York
$11.9M – – –
Raymond James Financial
5
Raymond James Financial
Florida
$8.1M +$861K +188,969 +9%
BlackRock
6
BlackRock
New York
$7.29M -$152K -33,307 -2%
Vanguard Group
7
Vanguard Group
Pennsylvania
$6.7M +$387K +84,968 +5%
EC
8
Euclidean Capital
New York
$5.74M – – –
SL
9
Siren LLC
Connecticut
$2.63M – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$2.52M +$35.7K +7,832 +1%
Point72 Asset Management
11
Point72 Asset Management
Connecticut
$2.28M -$43.5K -9,544 -2%
State Street
12
State Street
Massachusetts
$2.14M +$85.9K +18,850 +3%
AI
13
Alphabet Inc
California
$1.83M – – –
BC
14
Birchview Capital
Vermont
$1.13M – – –
DCM
15
DAFNA Capital Management
California
$1.11M +$538K +118,035 +63%
Northern Trust
16
Northern Trust
Illinois
$903K -$29K -6,366 -3%
Jacobs Levy Equity Management
17
Jacobs Levy Equity Management
New Jersey
$883K +$82.2K +18,036 +8%
SCM
18
Sio Capital Management
New York
$444K – – –
RWM
19
Rockwood Wealth Management
Pennsylvania
$392K – – –
SCM
20
SCS Capital Management
Massachusetts
$390K +$488K +106,980 New
Wellington Management Group
21
Wellington Management Group
Massachusetts
$376K +$72.1K +15,819 +18%
Charles Schwab
22
Charles Schwab
California
$276K – – –
Morgan Stanley
23
Morgan Stanley
New York
$254K -$128K -28,074 -29%
State of Wisconsin Investment Board
24
State of Wisconsin Investment Board
Wisconsin
$225K +$93K +20,400 +50%
N
25
Nuveen
North Carolina
$221K – – –
1
2 3 4

FHTX Hedge Fund Activity: Q1 2025 in Review

90 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Foghorn Therapeutics (FHTX) for Q1 2025, worth a combined $148M — down 22% from $190M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new FHTX positions and 5 closed out — a net gain of 3 holders — while 26 added to existing stakes and 30 trimmed.

The largest buyer was Raymond James Financial, adding an estimated $861K. The largest seller was Fidelity Investments, cutting an estimated $460K.

  • 90 institutional investors held Foghorn Therapeutics (FHTX) as of Q1 2025, up from 87 in Q4 2024.
  • Funds reported $148M of Foghorn Therapeutics stock for Q1 2025, down 22% quarter-over-quarter.
  • 8 funds opened new Foghorn Therapeutics positions in Q1 2025 and 5 closed out, a net change of +3 holders.
  • The largest Foghorn Therapeutics buyer in Q1 2025 was Raymond James Financial, an estimated $861K added.
  • The largest Foghorn Therapeutics seller in Q1 2025 was Fidelity Investments, an estimated $460K sold.

Based on aggregated 13F filings for Q1 2025.